SCHEMBL20866841

SCHEMBL20866841

COc1ccnc(C(=N)OC(=N)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1

nearest known ligand 0.50

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CCKBR P32239 17/20 0.50
▸ CCKAR P32238 12/20 0.50
▸ NOTCH1 P46531 1/20 0.47
▸ RBPJ Q06330 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20866833 0.88 CCKBR (0.51) CCKBRCCKAR
SCHEMBL20866994 0.86 CCKBR (0.55) CCKBRCCKAR
SCHEMBL20866984 0.86 CCKBR (0.55) CCKBRCCKAR
SCHEMBL20866565 0.85 CCKBR (0.58) CCKBRCCKAR
SCHEMBL20866971 0.84 CCKBR (0.52) CCKBRCCKAR
SCHEMBL20867001 0.84 CCKBR (0.52) CCKBRCCKAR
SCHEMBL20867015 0.83 CCKBR (0.58) CCKBRCCKAR
SCHEMBL20866589 0.82 CCKBR (0.52) CCKBRCCKAR
SCHEMBL20867304 0.82 CCKBR (0.52) CCKBRCCKAR
SCHEMBL20866659 0.81 CCKBR (0.62) CCKBRCCKAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3324977-B1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARM INC (US) 2022-07-13 — — EP disclosed
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback